Image_5_Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis.TIF by Yuanliang Yan (475094)

“…Our results suggest that the ADAMTS9-AS2/FUS/MDM2 axis may represent a suitable prognostic biomarker and a potential target in TMZ-resistant GBM therapy.…”

Data_Sheet_1_Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis.ZIP by Yuanliang Yan (475094)

“…Our results suggest that the ADAMTS9-AS2/FUS/MDM2 axis may represent a suitable prognostic biomarker and a potential target in TMZ-resistant GBM therapy.…”

Image_1_Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis.TIF by Yuanliang Yan (475094)

“…Our results suggest that the ADAMTS9-AS2/FUS/MDM2 axis may represent a suitable prognostic biomarker and a potential target in TMZ-resistant GBM therapy.…”

Image_3_Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis.TIF by Yuanliang Yan (475094)

“…Our results suggest that the ADAMTS9-AS2/FUS/MDM2 axis may represent a suitable prognostic biomarker and a potential target in TMZ-resistant GBM therapy.…”

Table_1_Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis.DOCX by Yuanliang Yan (475094)

“…Our results suggest that the ADAMTS9-AS2/FUS/MDM2 axis may represent a suitable prognostic biomarker and a potential target in TMZ-resistant GBM therapy.…”

Table_2_Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis.DOCX by Yuanliang Yan (475094)

“…Our results suggest that the ADAMTS9-AS2/FUS/MDM2 axis may represent a suitable prognostic biomarker and a potential target in TMZ-resistant GBM therapy.…”

Table_3_Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis.DOCX by Yuanliang Yan (475094)

“…Our results suggest that the ADAMTS9-AS2/FUS/MDM2 axis may represent a suitable prognostic biomarker and a potential target in TMZ-resistant GBM therapy.…”

Image_4_Novel Function of lncRNA ADAMTS9-AS2 in Promoting Temozolomide Resistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis.TIF by Yuanliang Yan (475094)

“…Our results suggest that the ADAMTS9-AS2/FUS/MDM2 axis may represent a suitable prognostic biomarker and a potential target in TMZ-resistant GBM therapy.…”

Table_2_Transient Viral Activation in Human T Cell Leukemia Virus Type 1-Infected Macaques Treated With Pomalidomide.XLSX by Anna Gutowska (687799)

Table_1_Transient Viral Activation in Human T Cell Leukemia Virus Type 1-Infected Macaques Treated With Pomalidomide.XLSX by Anna Gutowska (687799)

DataSheet1_Predicting protective gene biomarker of acute coronary syndrome by the circRNA-associated competitive endogenous RNA regulatory network.docx by Hengliang Zhang (13980072)

Image_2_Transient Viral Activation in Human T Cell Leukemia Virus Type 1-Infected Macaques Treated With Pomalidomide.PDF by Anna Gutowska (687799)

Injection of either <i>miR-3906-</i>MO or <i>homer-1b</i> mRNA affects fast muscle differentiation by regulating the calcium concentration in muscle cells. by Cheng-Yung Lin (403166)

Edge effect model fit for forest specialists in the understory. by Natalie Yoh (9075092)

“…<p>Log forest specialist activity (bat passes) per 50 m sample point averaged across all transects with corresponding lines of best fit. …”

Average turnaround time for varied number of Gridlets. by Hajara Idris (4031195)

“…In this experiment, 3,000 jobs are sent to the Grid with varying number of resources from 50 to 3,050, and as can be seen, increasing the number of resources has a decreasing exponential effect on the execution time. …”

Expression patterns of <i>Tnc</i> and <i>Nov</i> in the cochlea during neonatal development. by Eun Jin Son (151823)

“…<i>Nov</i> expression levels were relatively constant at P0 along the cochlear duct and gradually decreased toward the apex by P8 (D). Scale bar in A (200 µm) applies to B, C, and D; scale bar in A1 (50 µm) applies to A1–A3, B1–B3, C1–C3, and D1–D3.…”

NTP treatment altered the expression of FAK, Src, and paxillin. by Jae Won Chang (542513)

“…NTP treatment also decreased p-paxillin expression. Scale bar = 50 µm. …”

Resveratrol rescued SIRT1 and ROCK1 expression. by Xiaowen Feng (395828)

“…<p>SIRT1 and ROCK1 expressions were determined by Western blotting (A) and real time quantitative PCR (B and C). The 20 µM Aβ_25–35 significantly decreased protein (D) and mRNA (F) expression of SIRT1, but markedly increased protein (E) and mRNA (G) expression of ROCK1. …”

Blueberry pomace, valorization of an industry by-product source of fibre with antioxidant capacity by Camila TAGLIANI (6826577)

“…Cookie with 9% fibre, 180 °C baking temperature and 0.50 cm dough thickness and cookie with 9% of fibre, 170°C baking temperature and 0.75 cm dough thickness showed maximum antioxidant capacity and polyphenol content with no significant differences between them; both cookies can be labelled using a fibre claim.…”

Validation of mitochondrial Ca²⁺ measurements. by Yael Yaniv (162548)

“…<p>(A) Mn²⁺ (50 µmol/L) quenching of the cytosolic Indo-1 fluorescence ratio 410/490 (top panel), and fluorescence emission at wavelengths of 410 (middle panel), and 490 nm (lower panel). …”